Nanolattix Biotechnology Co., Ltd.
2 clinical trials · Sponsor
◉ Watch Nanolattix Biotechnology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors (NCT07434609) | Nanolattix Biotechnology Co., Ltd. | 2027-12-01 |
| Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors (NCT07505069) | Nanolattix Biotechnology Co., Ltd. | 2026-01-29 |
Track Nanolattix Biotechnology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.